Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Magnussen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Investigative Ophthalmology & Visual Science|March 19, 2010
Recombinant human VEGF165b inhibits experimental choroidal neovascularizationJing Hua, Christine Spee, Satoru Kase, et al.
Investigative Ophthalmology & Visual Science|March 19, 2010
VEGF-A165b is cytoprotective and antiangiogenic in the retinaAnette L Magnussen, Emma S Rennel, Jing Hua, et al.
British Journal of Cancer|June 22, 2021
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancerHanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Investigative Ophthalmology & Visual Science|March 19, 2010
Recombinant human VEGF165b inhibits experimental choroidal neovascularizationJing Hua, Christine Spee, Satoru Kase, et al.
Investigative Ophthalmology & Visual Science|March 19, 2010
VEGF-A165b is cytoprotective and antiangiogenic in the retinaAnette L Magnussen, Emma S Rennel, Jing Hua, et al.
British Journal of Cancer|June 22, 2021
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancerHanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, et al.
Pageof 2